Brain Res, 2016 · DOI: 10.1016/j.brainres.2015.07.026 · Published: May 1, 2016
Oligodendrocyte precursor cells (OPCs) react rapidly to brain and spinal cord injuries. This reaction is characterized by the retraction of cell processes, cell body swelling and increased expression of the NG2 chondroitin sulfate proteoglycan. The glial reaction to injury is an attempt to restore normal homeostasis and reestablish the glia limitans but the exact role of reactive OPCs in these processes is not well understood. Reactive OPCs, however, also are a source of axon-growth inhibitory proteoglycans and may interact with invading inflammatory cells in complex ways.
Understanding the regulation of disparate properties of OPCs may lead to new therapeutic approaches to devastating injuries of the spinal cord.
Reducing inflammation by reducing the reactions of OPCs may limit secondary damage after SCI.
A major challenge for the future will be how to reduce the detrimental effects of reactive OPCs on axon regrowth while preserving their ability to remyelinate spared nerve fibers and preserve functionality.